BioSpace News Archive

Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced it has appointed Julianne Averill, CPA, as Chief Financial Officer. I

AgilVax, Inc., a biopharmaceutical company that discovers and develops targeted antibody-based therapeutics to treat multiple types of cancer, announced today that the company has triggered Phase II funding worth $1.2 million from its Fast Track Small Business Innovation Research (SBIR) grant awarded by the National Cancer Institute (NCI).